Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02595866
Title Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)

Hodgkin's lymphoma

Kaposi's sarcoma

non-Hodgkin lymphoma

hepatocellular carcinoma

Advanced Solid Tumor


lung non-small cell carcinoma



Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Recruiting Birmingham Alabama 35233 United States Details
Zuckerberg San Francisco General Hospital Recruiting San Francisco California 94110 United States Details
UCSF Medical Center-Parnassus Recruiting San Francisco California 94143 United States Details
Yale University Suspended New Haven Connecticut 06520 United States Details
Louisiana State University Health Science Center Recruiting New Orleans Louisiana 70112 United States Details
University of Maryland/Greenebaum Cancer Center Recruiting Baltimore Maryland 21201 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Active, not recruiting Baltimore Maryland 21287 United States Details
National Institutes of Health Clinical Center Recruiting Bethesda Maryland 20892 United States Details
Roswell Park Cancer Institute Active, not recruiting Buffalo New York 14263 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone Recruiting New York New York 10016 United States Details
Mount Sinai Hospital Recruiting New York New York 10029 United States Details
Cancer Immunotherapy Trials Network Recruiting Seattle Washington 98109 United States Details
FHCC South Lake Union Recruiting Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field